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Abstract 
Introduction: The amount and type of fatty acids (FAs) in the diet influence the
risk of atherosclerosis. Palmitic acid and linoleic acid exist at high levels in Iran-
ian edible oils. In this study, we investigated the effect of palmitic acid and linole-
ic acid on expression of soluble and cell-associated forms of intercellular adhe-
sion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in
human bone marrow endothelial cells (HBMECs).
Material and methods: The endothelial cells were induced with bacterial
lipopolysaccharide (LPS) or tumor necrosis factor  α (TNF-α), and thereafter incu-
bated with palmitic or linoleic acid. The level of soluble and cell-associated
VCAM-1 and ICAM-1 were analyzed using ELISA and western blot. 
Results: Our findings indicated that palmitic acid up-regulates the expression
of ICAM-1 and VCAM-1 in HBMECs when these cells are induced with TNF-α or
LPS. In addition, the results suggest that linoleic acid could sustain up-regulat-
ed ICAM-1 and VCAM-1 in activated endothelial cells. 
Conclusions: Chronic activation of endothelial cells in the presence of palmitic
and linoleic may account for pathogenesis of cardiovascular events. These find-
ings provide further support for the detrimental effects of these fatty acids,
especially palmitic acid, in promotion and induction of cardiovascular diseases
which are prevalent in the Iranian population.
Key words: human bone marrow endothelial cells, intercellular adhesion molecu-
le-1, fatty acid, vascular cell adhesion molecule-1.
Introduction
Research conducted by the Iranian Nutrition Institute (INI) showed that
roughly 21% of the population's food intake results from the consumption
of edible oils. If the intake of other fats contained in other food products
are taken into account, this percentage would exceed 30%, the maximum
recommended amount of consumption. Iran will experience a significant
increase in both per capita and total consumption of edible oils and feed
meals over the next 10 years [1]. Palmitic acid (C16:0) and linoleic acid
(C18:2n6) are the most common saturated and polyunsaturated fatty acids
consumed in the Iranian population, respectively [2]. The amount and type
of fatty acids in the diet influence the risk of inflammatory disease and
atherosclerosis [3, 4]. Fats rich in long-chain saturated fatty acids (SFA)
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such as butter have been shown to exacerbate
postprandial lipemic responses [5]. Current dietary
recommendations for reducing cardiovascular dis-
ease (CVD) risk emphasize reducing the intake of
SFA (mainly palmitic acid) by increasing dietary
monounsaturated fatty acids (MUFA) [6, 7]. On the
other hand, the findings regarding the detrimental
effect of linoleic acid, n-6 polyunsaturated fatty
acids (PUFA) abundant in many vegetable oils, on
cardiovascular disease are controversial [8-12]. 
Atherosclerosis is thought to be initiated at crit-
ical sites of the arterial vasculature by a process of
leukocyte adhesion to the vessel wall, sustained by
the occurrence of active functional changes on the
endothelial surface [13]. Normally, vascular endothe-
lial cells have low adhesiveness for leukocytes. How-
ever, when stimulated, they express adhesion mol-
ecules at their surfaces responsible for firm
attachment/activation of leukocytes and initiation
of inflammation. The members of the immunoglob-
ulin gene superfamily of adhesion molecules, inter-
cellular adhesion molecule-1 (ICAM-1) and vascular
cell adhesion molecule-1 (VCAM-1), are among the
most prominent adhesion molecules. These adhe-
sion molecules interact with integrins at cellular
surfaces and control the traffic of leukocytes
between blood and tissues [14-17]. Human bone
marrow endothelial cells (HBMECs), a representa-
tive of microvascular endothelial cells, synthesize
the adhesion molecules to control the traffic of
hematopoietic cells from and to the blood [18-20]. 
Previously, we reported that elaidic acid sustains
ICAM-1 and VCAM-1 up-regulated by tumour necro-
sis factor α (TNF-α) or lipopolysaccharide (LPS) [21].
Herein, we have investigated the effect of palmitic
acid and linoleic acid, the two most common fatty
acids consumed in Iran, on expression of membrane
and secreted forms of VCAM-1 and ICAM-1 in
HBMECs, in order to determine the probable rela-
tionship between immoderate consumption of
these FAs and high atherosclerosis prevalence in
the Iranian population.
Material and methods
Chemicals and cells
Seventy five cm2 culture flasks, culture micro  -
plates (NUNC, Roskilde, Denmark), trypsin/ EDTA
solution, MCDB131, penicillin, streptomycin, ampho-
tericin B, fetal bovine serum (FBS) (Gibco, New York,
USA), free essential fatty acid – bovine serum albu-
min (FEFA-BSA), palmitic acid (C16), linoleic acid
(C18:2n6) and human recombinant TNF-α  (T 0157)
were purchased from Sigma (St. Louis, MO, USA). LPS
(31.6-25 Bacto) was purchased from DIFCO (Kansas,
USA). Monoclonal antibodies against VCAM-1
(AHT0603) and ICAM-1 (AHS5444), ELISA-based kits
(96 wells) for sICAM-1 (KHS4412/ KHS5411) and
sVCAM-1(KHT0611) were purchased from Biosource
(Invitrogen Corp. USA). Rabbit anti-mouse IgG (horse-
radish peroxidase conjugated) was prepared in our
laboratory. The HBMECs were kindly provided by
Dr. Manocher Mirshahi (College of Medical Sciences,
Tarbiat Modares University, Tehran, Iran). 
Endothelial cell culture 
The HBMECs at the 25th passage were cultured
in a complete medium containing MCDB131 sup-
plemented with 10% FBS, 100 Iu/ml penicillin, 100
μg/ml streptomycin in 75 cm2 culture flasks at 37°C
and 5% CO2. After reaching confluence, the cells
were treated with trypsin-EDTA and plated to yield
near-confluent cultures at the end of the experi-
ment. The freshly plated cells were allowed to
attach in standard growth medium for at least 
48 h. The HBMECs were pretreated with TNF-α  or
LPS for induction of adhesion molecule expression,
and then treated with palmitic or linoleic acid
according to the experimental design (see below). 
Experimental design 
Cultured HBMECs were incubated with two dif-
ferent concentrations of TNF-α (0.01 and 0.001
μg/ml) and three different concentrations of LPS
(0.1, 1 and 10 μg/ml) for 6, 12, 18 and 24 h to find
optimal concentrations and incubation times of
these stimulants. In separate experiments, the cul-
tured HBMECs were also incubated with three dif-
ferent concentrations (10, 50 and 100 μM) of fatty
acids (palmitic or linoleic acid) for 24, 48 and 72 h
to find optimal concentrations of these fatty acids
with minimal toxic effects. Palmitic and linoleic acid
were converted to their potassium salts through
the saponification method [22], then aliquoted
under an N2 stream, and stored at –80°C for no
longer than 5 months before use. At the time of the
experiments, fatty acids were dissolved in FEFA-BSA
at the final desired concentrations. The fatty acid
stock solutions were diluted in the medium to reach
fatty acid concentrations of 10 μM to 100 μM with
corresponding BSA concentrations of 2 μM to 
20 μM (molar ratio of fatty acid to albumin was 
5 : 1) [23]. Equivalent amounts of BSA alone were
added to control plates. At the end of these peri-
ods, the protein pattern (SDS-PAGE) and parame-
ters of cell viability (morphology, number and via-
bility (trypan blue exclusion)) were assessed. The
best concentrations with maximum viability and
protein expression for each TNF-α, LPS and fatty
acids were selected. All experiments were per-
formed at least in triplicate.
Fatty acid treatment 
Fatty acid (1000 μM)/BSA (200 mM) stock solu-
tions were prepared by dissolving FEFA-BSA and
Effect of palmitic acid and linoleic acid on expression of ICAM-1 and VCAM-1 in human bone marrow endothelial cells (HBMECs)194 Arch Med Sci 2, April / 2012
palmitic or linoleic acid (potassium salts) in normal
saline (sodium chloride 0.9% w/v). The filter-steril-
ized fatty acids-BSA mixture (0.5 ml) was added to
4.5 ml of fresh MCDB131 medium supplemented
with 10% fetal bovine serum (FBS) (final concen-
tration of fatty acids 100 μM). The cells incubated
in MCDB131 and BSA (20 mM) supplemented with
10% FCS in absence of fatty acids, TNF-α, or LPS
were used as negative controls.  
Detection of cell adhesion molecules
Assay of cell adhesion molecules was carried out
by both ELISA and western blot analysis.
ELISA
The HBMECs were cultured in 75 cm2 culture
flasks and allowed to reach confluence. After adding
the stimulants and fatty acids, soluble (in super-
natant) and cell-associated (in cell lysate) forms of
ICAM-1 and VCAM-1 were quantified using the
ELISA kits, based on a sandwich format. For prepa-
ration of cell lysate, the endothelial cells were
washed three times with PBS and solubilized in Tris-
HCl buffer (20 mM, pH 8.0), containing 1% NP-40,
1% CHAPS, 50 mM NaCl, 10% glycerol, 2 mM EDTA
and 1 mM PMSF overnight at 4°C. The cell lysate
was centrifuged at 10 000 ×g for 10 min at 4°C and
the clear supernatant was immediately used for
determination of ICAM-1 and VCAM-1. The data pre-
sented are means of triplicate determinations.
Western blot analysis
The HBMECs were grown to confluence in 
75 cm2 culture flasks, gently washed twice with ice-
cold Tris-HCl buffer (10 mM) containing 250 mM
sucrose and then lysed in 0.5 ml of lysis buffer
(20 mM Tris-HCl pH 7.4 containing 50 mM NaCl, 1%
NP-40, 10% glycerol, 1 mM PMSF, 2 mM EDTA and
10 μg/ml aprotinin). After 10 min on ice, cell lysates
were collected by centrifugation (14 000 ×g for 
15 min at 4°C). The supernatant was boiled in SDS-
PAGE sample buffer containing 10% SDS for 10 min
and resolved in 12.5% polyacrylamide separating
gels at 150 V. The resolved proteins were transferred
to polyvinylidene difluoride (PVDF) membrane using
tank blotting [24]. The membranes were rinsed 
3 times in phosphate buffered saline (PBS) con-
taining 0.05% (v/v) Tween 20, and then blocked in
PBS-BSA 2% (w/v) for 2 h. The membranes were
incubated overnight (12 h) in primary (mouse anti-
human VCAM-1 and ICAM-1 monoclonal antibod-
ies) and for 2 h in secondary (rabbit anti-mouse IgG,
HRP conjugated) antibodies after washing 5 times
in each step. Finally, the blots were exposed to HRP
substrate solution (TMB and H2O2) for detection of
target protein bands. The densities of ICAM-1 and
VCAM-1 bands were determined by Lab works ver-
sion 4.0 software (UVP, Upland, USA), and the ratios
of FAs/control multiplied by 100 and defined as rel-
ative expression of ICAM-1 and VCAM-1.
Statistical analysis
All tests were performed at least three times.
Findings of ELISA considered when variations in
intra- and inter-assays were less than 5% and 15%,
respectively. The results are expressed as mean 
± SD and were analyzed using either Student’s t
test for comparison between two groups or ANO-
VA (analysis of variance) for multiple comparisons.
Results were considered significant when p < 0.05. 
Results
Cultured HBMECs in the absence of stimulants
(LPS or TNF-α) or FAs (palmitic or linoleic acid)
expressed very low levels of ICAM-1 or VCAM-1. 
The results indicated that TNF-α at 1 ng/ml for 12 h 
and LPS at 10 μg/ml for 12 h induced optimal
expression of the adhesion molecules on HBMECs
with minimal toxic effects as compared to the con-
trol wells. Furthermore, palmitic and linoleic acid
up to 100 μM for 24 h or 48 h did not have a con-
siderable adverse effect on cell count and mor-
phology, and protein pattern as assessed by SDS-
PAGE (data not shown).
The results of ELISA for assay of cell-associated
ICAM-1 showed that TNF-α is a stronger stimulant
than LPS for expression of this adhesion molecule.
Conversely, LPS could induce sICAM-1 relatively bet-
ter than TNF-α. Furthermore, LPS could stimulate cell
associated and sVCAM-1 very strongly (Figures 1, 2).
Therefore, depending on the type of inducer (LPS or
TNF-α), one form of the adhesion molecule (soluble
Figure 1. Effect of palmitic and linoleic acid on level
of soluble and cell associated ICAM-1 and VCAM-1
in TNF-α -stimulated HBMECs. Cells pre-treated with
TNF-α, thereafter with palmitic and linoleic acid 
(100 μM for 24 h). Active-1 is HBMECs treated with
TNF-α (1 ng/ml for 12 h). Active-2 is active-1 cells in
culture medium without TNF-α  for additional 24 h.
Silent is HBMECs in culture medium without TNF-α
and fatty acid. Each column shows the mean ± SD
of triplicate determinations
*p < 0.05
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or cell-associated) was up-regulated more than the
other form. The results also indicated that these induc-
ers up-regulate VCAM-1 better than ICAM-1, in whole.
When HBMECs induced by LPS (10 μg/ml for 
12 h) or TNF-α (1 ng/ml for 12 h) were treated with
palmitic or linoleic acid (100 μM for 24 h), the lev-
el of the adhesion molecules changed remarkably.
Palmitic acid significantly enhanced the level of 
soluble and cell-associated ICAM-1 (ICAM-1 and
sICAM-1) and sustained the level of VCAM-1 and
sVCAM-1 in HBMECs when these cells induced with
LPS or TNF-α. In contrast, linoleic acid did not sig-
nificantly affect the level of soluble or cell associ-
ated forms of ICAM-1 in HBMECs pre-treated with
TNF-α or LPS, but to a small extent enhanced the
expression of VCAM-1, especially sVCAM-1, when
the cells were activated with TNF-α (Figures 1, 2).
Western blot analysis of total cell-associated
VCAM-1 and ICAM-1 following treatment of activat-
ed HBMECs with palmitic and linoleic acid is demon-
strated in Figures 3 and 4, respectively. These results
also indicated that palmitic acid significantly induces
the expression of ICAM-1 on HBMECs when these
cells are primed with TNF-α  or LPS, and sustains
up-regulated VCAM-1 at an activated level. In con-
trast, linoleic acid did not affect the level of ICAM-1
when HBMECs were pre-treated with TNF-α or LPS
and VCAM-1 when these cells were pre-treated with
TNF-α. However, linoleic acid decre  ased the level of
VCAM-1 when HBMECs were pre-treated with LPS. 
Discussion
A number of risk factors for CVD have been iden-
tified from epidemiological studies. These include
positive family history of CVD, cigarette smoking,
hypertension, elevated serum cholesterol, obesity,
diabetes, physical inactivity, sex, age and excessive
stress [25]. During the 1950s, considerable interest
began to develop concerning a possible relation-
ship between dietary fat and the incidence of coro-
nary heart disease (CHD) [26]. The relationship
Figure 2. Effect of palmitic and linoleic acid on level
of soluble and cell associated ICAM-1 and VCAM-1
in LPS-stimulated HBMECs. Cells pre-treated with
LPS, thereafter with palmitic and linoleic acid (100
μM for 24 h). Active-1 is HBMECs treated with LPS
(10 μg/ml for 12 h). Active-2 is active-1 cells in cul-
ture medium without LPS for additional 24 h. Silent
is HBMECs in culture medium without LPS and fat-
ty acid. Each column shows the mean ± SD of tripli-
cate determinations
*p < 0.05
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Figure 3. Western blot analysis of VCAM-1 after treat-
ment of HBMECs with palmitic and linoleic acid. Cells
stimulated with TNF-α and LPS, and then with
palmitic and linoleic acid. Cont-1 is HBMECs grown
in medium containing TNF-α or LPS. Cont-2 is cont-
1 cells in culture medium without TNF-α or LPS for
additional 24 h. Data are representative of three inde-
pendent experiments
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Figure 4. Western blot analysis of ICAM-1 after treat-
ment of HBMECs with palmitic and linoleic acid. Cells
stimulated with TNF-α and LPS, and then with
palmitic and linoleic acid. Cont-1 is HBMECs grown
in medium containing TNF-α  or LPS. Cont-2 is cont-
1 cells in culture medium without TNF-α or LPS for
additional 24 h. Data are representative of three inde-
pendent experiments
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between saturated fat intake and low density
lipoprotein (LDL) is direct and progressive, increas-
ing the risk of CVD [27]. According to the results
reported by Bahrami et al. [2], edible oil products
manufactured in Iran contain remarkably high lev-
els of trans and saturated fatty acids. In addition,
the main unsaturated fatty acid in many edible oils
consumed in Iran is linoleic acid. 
Saturated fatty acids (SFAs) are believed to con-
tribute to induction of CHD [28]. This understand-
ing is based on the evidence that accumulation of
SFA in vascular cells leads to lipid-mediated vascu-
lar cell dysfunction [29, 30]. Vascular endothelium,
as it is continuously exposed to free fatty acids,
plays a critical role in the development of vascular-
related diseases, including atherosclerosis, CAD,
and diabetes [31, 32]. The HBMECs express the 
cellular adhesion molecules ICAM-1 and PECAM 
and also VCAM-1 and ELAM-1 upon activation by
stimulatory cytokines such as TNF-α [33]. Our
results indicated that LPS, in comparison to TNF-α, 
is a more potent inducer for the soluble form of
ICAM-1 (sICAM-1) as well as soluble and cell asso-
ciated forms of VCAM-1. 
Epidemiological studies have shown that solu-
ble ICAM-1 (sICAM-1) is a predictor of CVD among
healthy individuals [34-36]. In contrast, levels of sol-
uble VCAM (sVCAM) do not predict primary onset
of CVD [36-38] but are markedly elevated in acute
coronary syndromes and may be a predictor of
death in patients with existing coronary artery dis-
ease [39, 40]. It has been suggested that sICAM-1
is a general marker of proinflammatory status in
a healthy population, whereas sVCAM-1 is
expressed primarily at an advanced stage of ath-
erosclerosis [40]. After up-regulation of the adhe-
sion molecules in HBMECs and treatment of these
cells with palmitic or linoleic acid, we found that
palmitic acid significantly increases the level of
ICAM-1 and sICAM-1, and sustains the level of
VCAM-1 and sVCAM-1. The results also indicated
that linoleic acid maintains the level of ICAM-1 and
VCAM-1 in stimulated HBMECs as assessed by
ELISA. However, the western blot results indicated
a small decrease in the level of VCAM-1. Therefore,
it is suggested that palmitic acid could keep the
HBMECs at the stimulated phenotype through
increased levels of the two forms of ICAM-1 and
maintained level of VCAM-1. These findings are con-
sistent with other studies concerning the effect of
palmitic acid on up-regulation of adhesion mole-
cules in endothelial cells such as human coronary
artery endothelial cells and human umbilical vein
endothelial cells (HUVECs) [5, 41, 42]. Our results
also indicated that linoleic acid maintains the lev-
el of ICAM-1 at an activated level, and could not
lower the VCAM-1 significantly in TNF-α or LPS-
induced HBMECs. These findings collectively sug-
gested that the in vitro atherogenic effect of linole-
ic acid on HBMECs exceeds its anti-atherogenic
effect. Our results are in concordance with several
reports about the effect of linoleic acid on up-reg-
ulation of adhesion molecules and adhesiveness of
endothelial cells [43-46]. Both ICAM-1 and VCAM-1
together mediate adhesion of leukocytes to the
activated endothelium and transmigration into the
sub-endothelial space [47]. Expression of both
VCAM-1 and ICAM-1 is up-regulated in atheroscle-
rotic lesions, although VCAM-1 plays a dominant
role in the initiation of atherosclerosis [48]. Since
the expression of VCAM-1 occurs only on activated
endothelial cells, it may be used as a specific mark-
er of plaque burden or activity. Furthermore, levels
of VCAM-1 are prognostically important in acute
coronary syndromes [49-51]. Most studies report
high plasma concentrations of sVCAM-1 and sICAM-
1 in coronary artery disease irrespective of stabili-
ty [52-55].
Collectively, our results indicated that palmitic
acid could up-regulate the expression of ICAM-1
and VCAM-1 in HBMECs pretreated with stimula-
tory agents such as pro-inflammatory cytokines or
bacterial LPS. In addition, the results suggested that
linoleic acid can sustain up-regulated ICAM-1 and
VCAM-1 in activated endothelial cells. Therefore,
chronic activation of endothelial cells in the pres-
ence of deleterious fatty acids may play a pivotal
role in pathogenesis of cardiovascular events. These
findings provided further support on the detri-
mental effects of these fatty acids, specially palmitic
acid, in promotion and induction of cardiovascular
diseases which are prevalent in the Iranian popu-
lation. However, more research is needed to char-
acterize the mechanism underlying these effects.
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